<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Major Depressive Disorder - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    
    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Major Depressive Disorder</span>
        </nav>

        <header class="page-header">
            <h1>Major Depressive Disorder</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Complex</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0002009" target="_blank">
                        MONDO:0002009
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Psychiatric Disease</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Mood Disorder</span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">7</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">7</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
        </div>

        <!-- Classifications -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üè∑</div>
                <h2 class="card-title">Classifications</h2>
            </div>
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Harrison's Chapter</div>
                <div class="tag-list">
                    
                    <span class="tag tag-classification">psychiatric disorder</span>
                    
                </div>
            </div>
            
            
            
            
            
            
        </div>
        

        <!-- Subtypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #eef2ff; color: #4f46e5;">‚óÜ</div>
                <h2 class="card-title">Subtypes</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Melancholic Depression</div>
                
                <div class="item-desc">Characterized by anhedonia, psychomotor changes, and diurnal variation.</div>
                
                
    
    
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Atypical Depression</div>
                
                <div class="item-desc">Features mood reactivity, hypersomnia, hyperphagia, and rejection sensitivity.</div>
                
                
    
    
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Psychotic Depression</div>
                
                <div class="item-desc">Depression with hallucinations or delusions.</div>
                
                
    
    
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Seasonal Affective Disorder</div>
                
                <div class="item-desc">Depression recurring in winter months.</div>
                
                
    
    
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Peripartum Depression</div>
                
                <div class="item-desc">Depression during pregnancy or postpartum period.</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Monoamine Deficiency</div>
                
                <div class="item-desc">Reduced serotonin, norepinephrine, and dopamine neurotransmission in key brain circuits. While oversimplified, this remains a foundation for antidepressant pharmacotherapy.
</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Serotonin Signaling
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007210" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Dopamine Signaling
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007212" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38331979" target="_blank">PMID:38331979</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"</div>
                
                
                <div class="evidence-explanation">This review confirms the neurotransmitter hypothesis as a foundational theory of MDD pathogenesis, though it notes that multiple hypotheses are needed to fully explain the disorder.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39150594" target="_blank">PMID:39150594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"MDD is especially burdensome as approved monoamine antidepressant treatments have weeks-long delays before clinical benefit and low remission rates."</div>
                
                
                <div class="evidence-explanation">This highlights the clinical reality of monoamine-based treatments, confirming their use while acknowledging their limitations in achieving remission.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38474387" target="_blank">PMID:38474387</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity."</div>
                
                
                <div class="evidence-explanation">This demonstrates how inflammatory mechanisms contribute to decreased serotonin synthesis, supporting the monoamine deficiency theory while connecting it to broader pathophysiological processes.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">HPA Axis Dysregulation</div>
                
                <div class="item-desc">Hyperactivity of the hypothalamic-pituitary-adrenal axis leads to elevated cortisol, which may contribute to hippocampal atrophy and cognitive symptoms.
</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Cortisol Response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0071385" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38331979" target="_blank">PMID:38331979</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"</div>
                
                
                <div class="evidence-explanation">This review identifies the HPA axis hypothesis as one of the widely accepted core pathophysiological mechanisms in MDD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Neuroplasticity Deficits</div>
                
                <div class="item-desc">Reduced BDNF and impaired synaptic plasticity in prefrontal cortex and hippocampus. Successful treatments restore neuroplasticity.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Neuron
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000540" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Synaptic Plasticity
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0048167" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38331979" target="_blank">PMID:38331979</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"</div>
                
                
                <div class="evidence-explanation">This comprehensive review identifies the neuroplasticity hypothesis as one of the core accepted mechanisms in MDD pathogenesis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39150594" target="_blank">PMID:39150594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"This narrative review provides a high-level overview of glutamate signaling in synaptogenesis and neural plasticity and the implications of glutamate dysregulation in depression."</div>
                
                
                <div class="evidence-explanation">This demonstrates the link between glutamate signaling, synaptogenesis, and neural plasticity deficits in depression, supporting the neuroplasticity deficit mechanism.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38474387" target="_blank">PMID:38474387</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity."</div>
                
                
                <div class="evidence-explanation">This shows how inflammatory processes lead to impairments in neuroplasticity-related mechanisms, connecting inflammation to neuroplasticity deficits in MDD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Neuroinflammation</div>
                
                <div class="item-desc">Elevated inflammatory cytokines (IL-6, TNF-alpha, CRP) observed in depression. Inflammation may contribute to monoamine depletion and neuroplasticity deficits.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Microglia
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000129" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38331979" target="_blank">PMID:38331979</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"</div>
                
                
                <div class="evidence-explanation">This review identifies the cytokine hypothesis as one of the widely accepted theories of MDD pathogenesis, supporting the role of inflammatory mechanisms.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38474387" target="_blank">PMID:38474387</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The involvement of central and peripheral inflammation in the pathogenesis and prognosis of major depressive disorder (MDD) has been demonstrated. The increase of pro-inflammatory cytokines (interleukin (IL)-1Œ≤, IL-6, IL-18, and TNF-Œ±) in individuals with depression may elicit neuroinflammatory..."</div>
                
                
                <div class="evidence-explanation">This provides direct evidence for elevated pro-inflammatory cytokines in MDD and their role in eliciting neuroinflammatory processes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38474387" target="_blank">PMID:38474387</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"mechanisms that, in turn, can contribute to gut microbiota dysbiosis. Together, neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity."</div>
                
                
                <div class="evidence-explanation">This demonstrates how neuroinflammation contributes to both monoamine depletion (decreased serotonin) and neuroplasticity deficits, confirming the description&#39;s mechanistic links.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Mitochondrial Dysfunction</div>
                
                <div class="item-desc">Impaired mitochondrial respiration and cellular energy metabolism contribute to MDD pathophysiology. Patient-derived cells show decreased mitochondrial function, altered membrane potential, and disrupted calcium homeostasis.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38256041" target="_blank">PMID:38256041</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The link between mitochondria and major depressive disorder (MDD) is increasingly evident, underscored both by mitochondria&#39;s involvement in many mechanisms identified in depression and the high prevalence of MDD in individuals with mitochondrial disorders."</div>
                
                
                <div class="evidence-explanation">This establishes the connection between mitochondrial dysfunction and MDD, noting both mechanistic involvement and epidemiological evidence.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38256041" target="_blank">PMID:38256041</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Similarities were observed between the Mito patient and a broader MDD cohort, including decreased respiration and mitochondrial function."</div>
                
                
                <div class="evidence-explanation">This provides direct evidence from patient-derived cells showing decreased mitochondrial respiration and function in MDD patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38256041" target="_blank">PMID:38256041</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"the Non-R patient&#39;s data offered a new perspective on MDD, suggesting a detrimental imbalance in mitochondrial and cellular processes, rather than simply reduced functions."</div>
                
                
                <div class="evidence-explanation">This suggests that mitochondrial dysfunction in MDD may involve complex imbalances beyond simple reduction, including altered respiratory rates and calcium homeostasis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">7</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Depressed Mood
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Psychiatric</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0000716" target="_blank">
                            HP:0000716
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Anhedonia
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Psychiatric</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0012154" target="_blank">
                            HP:0012154
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Loss of interest or pleasure</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Sleep Disturbance
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Sleep</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002360" target="_blank">
                            HP:0002360
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Insomnia or hypersomnia</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Fatigue
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Systemic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0012378" target="_blank">
                            HP:0012378
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Poor Appetite
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Systemic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0004396" target="_blank">
                            HP:0004396
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Decreased or increased appetite</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Concentration Difficulties
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Cognitive</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0100543" target="_blank">
                            HP:0100543
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Psychomotor Changes
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Neurological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001266" target="_blank">
                            HP:0001266
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Retardation or agitation</div>
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">üß¨</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    SLC6A4
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Risk Factor)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    BDNF
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Risk Factor)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    FKBP5
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Risk Factor)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    HTR2A
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Risk Factor)</span>
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">7</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Selective Serotonin Reuptake Inhibitors (SSRIs)
                    
                </div>
                
                <div class="item-desc">First-line pharmacotherapy (sertraline, escitalopram, fluoxetine).</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39150594" target="_blank">PMID:39150594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"MDD is especially burdensome as approved monoamine antidepressant treatments have weeks-long delays before clinical benefit and low remission rates."</div>
                
                
                <div class="evidence-explanation">This confirms the clinical use of monoamine antidepressants while acknowledging their limitations in terms of delayed benefit and incomplete remission.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
                    
                </div>
                
                <div class="item-desc">Venlafaxine, duloxetine for depression with pain or fatigue.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Cognitive Behavioral Therapy
                    
                </div>
                
                <div class="item-desc">Evidence-based psychotherapy, comparable efficacy to medications.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Electroconvulsive Therapy
                    
                </div>
                
                <div class="item-desc">Most effective treatment for severe or treatment-resistant depression.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Ketamine/Esketamine
                    
                </div>
                
                <div class="item-desc">Rapid-acting treatment for treatment-resistant depression.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39150594" target="_blank">PMID:39150594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Nasal administration of esketamine (Spravato¬Æ) was approved by the US Food and Drug Administration (FDA) in 2019 to treat adults with treatment-resistant depression and in 2020 for adults with MDD with acute suicidal ideation or behavior."</div>
                
                
                <div class="evidence-explanation">This confirms FDA approval of esketamine for treatment-resistant depression and acute suicidal ideation/behavior in MDD.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39150594" target="_blank">PMID:39150594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Based on this preclinical evidence implicating glutamate in depression and the rapid improvement of depression with ketamine treatment in a proof-of-concept trial, a range of N-methyl-D-aspartate (NMDA)-targeted therapies have been investigated."</div>
                
                
                <div class="evidence-explanation">This explains the mechanistic basis for ketamine&#39;s rapid-acting antidepressant effects through NMDA receptor antagonism and glutamate modulation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39150594" target="_blank">PMID:39150594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Oral combination dextromethorphan-bupropion (AXS-05, Auvelity¬Æ extended-release tablet) was FDA approved in 2022 for the treatment of MDD in adults."</div>
                
                
                <div class="evidence-explanation">This documents the approval of another glutamatergic modulator for MDD treatment, expanding treatment options beyond esketamine.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Transcranial Magnetic Stimulation
                    
                </div>
                
                <div class="item-desc">Non-invasive neuromodulation for treatment-resistant depression.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Behavioral Activation
                    
                </div>
                
                <div class="item-desc">Increasing engagement in rewarding activities.</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">üåç</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Childhood Trauma</div>
                
                <div class="item-desc">Strong risk factor for adult depression</div>
                
                
                
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Chronic Stress</div>
                
                <div class="item-desc">Major precipitant</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38331979" target="_blank">PMID:38331979</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"</div>
                
                
                <div class="evidence-explanation">The HPA axis hypothesis directly relates to stress response dysregulation, supporting chronic stress as a major environmental precipitant of MDD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Social Isolation</div>
                
                <div class="item-desc">Risk factor and consequence</div>
                
                
                
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Substance Abuse</div>
                
                <div class="item-desc">Bidirectional relationship</div>
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üî¨</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Cortisol
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                <div class="item-desc">Context: HPA axis hyperactivity</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38331979" target="_blank">PMID:38331979</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"</div>
                
                
                <div class="evidence-explanation">The HPA axis hypothesis supports elevated cortisol as a key biochemical feature of MDD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    BDNF
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                <div class="item-desc">Context: Reduced neuroplasticity marker</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38474387" target="_blank">PMID:38474387</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity."</div>
                
                
                <div class="evidence-explanation">This demonstrates how neuroplasticity-related mechanisms are impaired in MDD, which is consistent with decreased BDNF as a neuroplasticity marker.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Inflammatory Markers
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                <div class="item-desc">Context: IL-6, CRP, TNF-alpha</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38474387" target="_blank">PMID:38474387</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The increase of pro-inflammatory cytokines (interleukin (IL)-1Œ≤, IL-6, IL-18, and TNF-Œ±) in individuals with depression may elicit neuroinflammatory processes and peripheral inflammation"</div>
                
                
                <div class="evidence-explanation">This directly confirms elevated inflammatory cytokines including IL-6 and TNF-Œ± in MDD patients.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Major Depressive Disorder
category: Complex
parents:
- Psychiatric Disease
- Mood Disorder
disease_term:
  preferred_term: major depressive disorder
  term:
    id: MONDO:0002009
    label: major depressive disorder
has_subtypes:
- name: Melancholic Depression
  description: Characterized by anhedonia, psychomotor changes, and diurnal variation.
- name: Atypical Depression
  description: Features mood reactivity, hypersomnia, hyperphagia, and rejection sensitivity.
- name: Psychotic Depression
  description: Depression with hallucinations or delusions.
- name: Seasonal Affective Disorder
  description: Depression recurring in winter months.
- name: Peripartum Depression
  description: Depression during pregnancy or postpartum period.
pathophysiology:
- name: Monoamine Deficiency
  description: &gt;
    Reduced serotonin, norepinephrine, and dopamine neurotransmission in
    key brain circuits. While oversimplified, this remains a foundation
    for antidepressant pharmacotherapy.
  biological_processes:
  - preferred_term: Serotonin Signaling
    term:
      id: GO:0007210
      label: serotonin receptor signaling pathway
  - preferred_term: Dopamine Signaling
    term:
      id: GO:0007212
      label: dopamine receptor signaling pathway
  evidence:
  - reference: PMID:38331979
    supports: SUPPORT
    snippet: &#34;The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis&#34;
    explanation: This review confirms the neurotransmitter hypothesis as a foundational theory of MDD pathogenesis, though it notes that multiple hypotheses are needed to fully explain the disorder.
  - reference: PMID:39150594
    supports: SUPPORT
    snippet: &#34;MDD is especially burdensome as approved monoamine antidepressant treatments have weeks-long delays before clinical benefit and low remission rates.&#34;
    explanation: This highlights the clinical reality of monoamine-based treatments, confirming their use while acknowledging their limitations in achieving remission.
  - reference: PMID:38474387
    supports: SUPPORT
    snippet: &#34;neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity.&#34;
    explanation: This demonstrates how inflammatory mechanisms contribute to decreased serotonin synthesis, supporting the monoamine deficiency theory while connecting it to broader pathophysiological processes.
- name: HPA Axis Dysregulation
  description: &gt;
    Hyperactivity of the hypothalamic-pituitary-adrenal axis leads to
    elevated cortisol, which may contribute to hippocampal atrophy and
    cognitive symptoms.
  biological_processes:
  - preferred_term: Cortisol Response
    term:
      id: GO:0071385
      label: cellular response to glucocorticoid stimulus
  evidence:
  - reference: PMID:38331979
    supports: SUPPORT
    snippet: &#34;The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis&#34;
    explanation: This review identifies the HPA axis hypothesis as one of the widely accepted core pathophysiological mechanisms in MDD.
- name: Neuroplasticity Deficits
  description: &gt;
    Reduced BDNF and impaired synaptic plasticity in prefrontal cortex
    and hippocampus. Successful treatments restore neuroplasticity.
  cell_types:
  - preferred_term: Neuron
    term:
      id: CL:0000540
      label: neuron
  biological_processes:
  - preferred_term: Synaptic Plasticity
    term:
      id: GO:0048167
      label: regulation of synaptic plasticity
  evidence:
  - reference: PMID:38331979
    supports: SUPPORT
    snippet: &#34;The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis&#34;
    explanation: This comprehensive review identifies the neuroplasticity hypothesis as one of the core accepted mechanisms in MDD pathogenesis.
  - reference: PMID:39150594
    supports: SUPPORT
    snippet: &#34;This narrative review provides a high-level overview of glutamate signaling in synaptogenesis and neural plasticity and the implications of glutamate dysregulation in depression.&#34;
    explanation: This demonstrates the link between glutamate signaling, synaptogenesis, and neural plasticity deficits in depression, supporting the neuroplasticity deficit mechanism.
  - reference: PMID:38474387
    supports: SUPPORT
    snippet: &#34;neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity.&#34;
    explanation: This shows how inflammatory processes lead to impairments in neuroplasticity-related mechanisms, connecting inflammation to neuroplasticity deficits in MDD.
- name: Neuroinflammation
  description: &gt;
    Elevated inflammatory cytokines (IL-6, TNF-alpha, CRP) observed in
    depression. Inflammation may contribute to monoamine depletion and
    neuroplasticity deficits.
  cell_types:
  - preferred_term: Microglia
    term:
      id: CL:0000129
      label: microglial cell
  evidence:
  - reference: PMID:38331979
    supports: SUPPORT
    snippet: &#34;The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis&#34;
    explanation: This review identifies the cytokine hypothesis as one of the widely accepted theories of MDD pathogenesis, supporting the role of inflammatory mechanisms.
  - reference: PMID:38474387
    supports: SUPPORT
    snippet: &#34;The involvement of central and peripheral inflammation in the pathogenesis and prognosis of major depressive disorder (MDD) has been demonstrated. The increase of pro-inflammatory cytokines (interleukin (IL)-1Œ≤, IL-6, IL-18, and TNF-Œ±) in individuals with depression may elicit neuroinflammatory processes and peripheral inflammation&#34;
    explanation: This provides direct evidence for elevated pro-inflammatory cytokines in MDD and their role in eliciting neuroinflammatory processes.
  - reference: PMID:38474387
    supports: SUPPORT
    snippet: &#34;mechanisms that, in turn, can contribute to gut microbiota dysbiosis. Together, neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity.&#34;
    explanation: This demonstrates how neuroinflammation contributes to both monoamine depletion (decreased serotonin) and neuroplasticity deficits, confirming the description&#39;s mechanistic links.
- name: Mitochondrial Dysfunction
  description: &gt;
    Impaired mitochondrial respiration and cellular energy metabolism contribute to
    MDD pathophysiology. Patient-derived cells show decreased mitochondrial function,
    altered membrane potential, and disrupted calcium homeostasis.
  evidence:
  - reference: PMID:38256041
    supports: SUPPORT
    snippet: &#34;The link between mitochondria and major depressive disorder (MDD) is increasingly evident, underscored both by mitochondria&#39;s involvement in many mechanisms identified in depression and the high prevalence of MDD in individuals with mitochondrial disorders.&#34;
    explanation: This establishes the connection between mitochondrial dysfunction and MDD, noting both mechanistic involvement and epidemiological evidence.
  - reference: PMID:38256041
    supports: SUPPORT
    snippet: &#34;Similarities were observed between the Mito patient and a broader MDD cohort, including decreased respiration and mitochondrial function.&#34;
    explanation: This provides direct evidence from patient-derived cells showing decreased mitochondrial respiration and function in MDD patients.
  - reference: PMID:38256041
    supports: SUPPORT
    snippet: &#34;the Non-R patient&#39;s data offered a new perspective on MDD, suggesting a detrimental imbalance in mitochondrial and cellular processes, rather than simply reduced functions.&#34;
    explanation: This suggests that mitochondrial dysfunction in MDD may involve complex imbalances beyond simple reduction, including altered respiratory rates and calcium homeostasis.
phenotypes:
- name: Depressed Mood
  category: Psychiatric
  frequency: VERY_FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Depression
    term:
      id: HP:0000716
      label: Depression
- name: Anhedonia
  category: Psychiatric
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Loss of interest or pleasure
  phenotype_term:
    preferred_term: Anhedonia
    term:
      id: HP:0012154
      label: Anhedonia
- name: Sleep Disturbance
  category: Sleep
  frequency: VERY_FREQUENT
  notes: Insomnia or hypersomnia
  phenotype_term:
    preferred_term: Sleep Disturbance
    term:
      id: HP:0002360
      label: Sleep disturbance
- name: Fatigue
  category: Systemic
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
- name: Poor Appetite
  category: Systemic
  frequency: FREQUENT
  notes: Decreased or increased appetite
  phenotype_term:
    preferred_term: Poor Appetite
    term:
      id: HP:0004396
      label: Poor appetite
- name: Concentration Difficulties
  category: Cognitive
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Cognitive Impairment
    term:
      id: HP:0100543
      label: Cognitive impairment
- name: Psychomotor Changes
  category: Neurological
  frequency: OCCASIONAL
  notes: Retardation or agitation
  phenotype_term:
    preferred_term: Psychomotor Abnormality
    term:
      id: HP:0001266
      label: Choreoathetosis
biochemical:
- name: Cortisol
  presence: Elevated
  context: HPA axis hyperactivity
  evidence:
  - reference: PMID:38331979
    supports: SUPPORT
    snippet: &#34;The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis&#34;
    explanation: The HPA axis hypothesis supports elevated cortisol as a key biochemical feature of MDD.
- name: BDNF
  presence: Decreased
  context: Reduced neuroplasticity marker
  evidence:
  - reference: PMID:38474387
    supports: SUPPORT
    snippet: &#34;neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity.&#34;
    explanation: This demonstrates how neuroplasticity-related mechanisms are impaired in MDD, which is consistent with decreased BDNF as a neuroplasticity marker.
- name: Inflammatory Markers
  presence: Elevated
  context: IL-6, CRP, TNF-alpha
  evidence:
  - reference: PMID:38474387
    supports: SUPPORT
    snippet: &#34;The increase of pro-inflammatory cytokines (interleukin (IL)-1Œ≤, IL-6, IL-18, and TNF-Œ±) in individuals with depression may elicit neuroinflammatory processes and peripheral inflammation&#34;
    explanation: This directly confirms elevated inflammatory cytokines including IL-6 and TNF-Œ± in MDD patients.
genetic:
- name: SLC6A4
  association: Risk Factor
  notes: Serotonin transporter gene
- name: BDNF
  association: Risk Factor
  notes: Val66Met polymorphism
- name: FKBP5
  association: Risk Factor
  notes: HPA axis regulation
- name: HTR2A
  association: Risk Factor
  notes: Serotonin receptor gene
environmental:
- name: Childhood Trauma
  notes: Strong risk factor for adult depression
- name: Chronic Stress
  notes: Major precipitant
  evidence:
  - reference: PMID:38331979
    supports: SUPPORT
    snippet: &#34;The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis&#34;
    explanation: The HPA axis hypothesis directly relates to stress response dysregulation, supporting chronic stress as a major environmental precipitant of MDD.
- name: Social Isolation
  notes: Risk factor and consequence
- name: Substance Abuse
  notes: Bidirectional relationship
treatments:
- name: Selective Serotonin Reuptake Inhibitors (SSRIs)
  description: First-line pharmacotherapy (sertraline, escitalopram, fluoxetine).
  evidence:
  - reference: PMID:39150594
    supports: SUPPORT
    snippet: &#34;MDD is especially burdensome as approved monoamine antidepressant treatments have weeks-long delays before clinical benefit and low remission rates.&#34;
    explanation: This confirms the clinical use of monoamine antidepressants while acknowledging their limitations in terms of delayed benefit and incomplete remission.
- name: Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
  description: Venlafaxine, duloxetine for depression with pain or fatigue.
- name: Cognitive Behavioral Therapy
  description: Evidence-based psychotherapy, comparable efficacy to medications.
- name: Electroconvulsive Therapy
  description: Most effective treatment for severe or treatment-resistant depression.
- name: Ketamine/Esketamine
  description: Rapid-acting treatment for treatment-resistant depression.
  evidence:
  - reference: PMID:39150594
    supports: SUPPORT
    snippet: &#34;Nasal administration of esketamine (Spravato¬Æ) was approved by the US Food and Drug Administration (FDA) in 2019 to treat adults with treatment-resistant depression and in 2020 for adults with MDD with acute suicidal ideation or behavior.&#34;
    explanation: This confirms FDA approval of esketamine for treatment-resistant depression and acute suicidal ideation/behavior in MDD.
  - reference: PMID:39150594
    supports: SUPPORT
    snippet: &#34;Based on this preclinical evidence implicating glutamate in depression and the rapid improvement of depression with ketamine treatment in a proof-of-concept trial, a range of N-methyl-D-aspartate (NMDA)-targeted therapies have been investigated.&#34;
    explanation: This explains the mechanistic basis for ketamine&#39;s rapid-acting antidepressant effects through NMDA receptor antagonism and glutamate modulation.
  - reference: PMID:39150594
    supports: SUPPORT
    snippet: &#34;Oral combination dextromethorphan-bupropion (AXS-05, Auvelity¬Æ extended-release tablet) was FDA approved in 2022 for the treatment of MDD in adults.&#34;
    explanation: This documents the approval of another glutamatergic modulator for MDD treatment, expanding treatment options beyond esketamine.
- name: Transcranial Magnetic Stimulation
  description: Non-invasive neuromodulation for treatment-resistant depression.
- name: Behavioral Activation
  description: Increasing engagement in rewarding activities.
classifications:
  harrisons_chapter:
    - classification_value: psychiatric disorder
datasets:
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Major_Depressive_Disorder.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>